Table 1.
Names, structures, and inhibition constants of co-crystalized 5-HT2AR and 5-HT2BR ligands.
PDB ID P (Mechanism) a |
Compound’s Structure |
pKi | Ref. | PDB ID P (Mechanism) a |
Compound’s Structure |
pKi | Ref. |
---|---|---|---|---|---|---|---|
5-HT2AR ligand |
7WC7 AG |
![]() |
8.55 | [26] | |||
6A93 FA a |
![]() |
8.16 | [16] |
7WC8 AG |
![]() |
9.27 | [26] |
6A94 FA |
![]() |
7.40 | [16] |
7WC9 AG |
![]() |
NA | [26] |
6WGT 7WC6 AG |
![]() |
8.63 | [16] [26] |
5-HT2BR ligand | |||
6WH4 IA |
![]() |
9.70 | [25] |
4NC3 4IB4 5TUD AG |
![]() |
8.88 | [29] [29] [31] |
6WHA PA |
![]() |
9.08 | [25] |
5TVN AG |
![]() |
NA | [31] |
7RAN AG |
![]() |
NA a | [27] |
6DRX AG |
![]() |
8.88 | [33] |
7VOD FA |
![]() |
7.73 | [28] |
6DRY 7SRQ 7SRS 7SRR AG |
![]() |
9.33 | [33] [32] [32] [32] |
7VOE FA |
![]() |
8.47 | [28] |
6DRZ AG |
![]() |
10 | [33] |
7WC4 AG |
![]() |
7.49 | [26] |
6DS0
FA |
![]() |
NA | [33] |
7WC5 AG PA |
![]() |
NA | [26] |
a Pharmacology: AG—agonist, IA—inverse agonist, PA—partial agonist, FA—full antagonist